Thrombosis
News
Team discovers new mechanisms of platelet formation
in the bone marrow Researchers have found that megakaryocytes can produce platelets via different polyploidization mechanisms. Experiments...
News
NICE recommends rivaroxaban for ACS
Credit: NHS In its final draft guidance, the UK’s National Institute for Health and Care Excellence (NICE) is recommending rivaroxaban (Xarelto)...
News
EMA wants to suspend drugs due to data manipulation
Credit: Steven Harbour The European Medicines Agency (EMA) has recommended suspending a number of drugs that were approved in the European Union...
News
CHMP recommends products for thrombosis, hemostasis
Credit: Piotr Bodzek The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) is recommending approval for the...
News
Label changes report new side effects for hematology drugs
Credit: CDC Several hematology drugs approved by the US Food and Drug Administration (FDA) have recently undergone label changes to reflect newly...
News
Real-world data with rivaroxaban similar to trial data
Credit: CDC A post-marketing study in patients with non-valvular atrial fibrillation (NVAF) suggests that rates and patterns of major bleeding...
Conference Coverage
New test could improve warfarin monitoring
SAN FRANCISCO—Monitoring warfarin using a modified prothrombin time (PT) test can improve anticoagulation stability and long-term clinical...
News
Drug reverses anticoagulation activity of rivaroxaban
Credit: Kevin MacKenzie An intravenous (IV) bolus of the factor Xa inhibitor antidote andexanet alfa can significantly and immediately reverse...
News
Edoxaban approved for atrial fib, DVT, and PE indications
News
FDA approves oral anticoagulant for NVAF, VTE
Credit: FDA The US Food and Drug Administration (FDA) has approved the oral, direct factor Xa inhibitor edoxaban (Savaysa) for use in two patient...
Conference Coverage
Drug reverses dabigatran’s effects in elderly/impaired
Credit: CDC SAN FRANCISCO—An investigational, humanized antibody fragment known as idarucizumab can reverse the anticoagulation effects of...